---
title: "physostigmine - Open-angle glaucoma"
sidebar: mydoc_sidebar
permalink: physostigmineopenangleglaucoma.html
toc: false 
---

{% include image.html file="physostigmineopenangleglaucoma.png" alt="physostigmineopenangleglaucoma" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D010830 | Physostigmine | Drug |
| UniProt:P22303 | acetylcholinesterase | Protein |
| MESH:D000109 | acetylcholine | ChemicalSubstance |
| GO:0045202 | synapse | CellularComponent |
| InterPro:IPR002394 | nicotinic acetylcholine receptors | GeneFamily |
| MESH:D005902 | Open-angle glaucoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Physostigmine | DECREASES ACTIVITY OF | Acetylcholinesterase |
| Acetylcholinesterase | INCREASES ABUNDANCE OF | Acetylcholine |
| Acetylcholine | LOCATED IN | Synapse |
| Synapse | INCREASES ACTIVITY OF | Nicotinic Acetylcholine Receptors |
| Nicotinic Acetylcholine Receptors | TREATS | Open-Angle Glaucoma |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00981#mechanism-of-action](https://go.drugbank.com/drugs/DB00981#mechanism-of-action){:target="_blank"}